Retainer adapter assembly
Latest Regeneron Pharmaceuticals, Inc. Patents:
- IL12 RECEPTOR AGONISTS AND METHODS OF USE THEREOF
- Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitors
- Eukaryotic cells comprising adenovirus-associated virus polynucleotides
- Hydrophobic interaction chromatography for viral clearance
- Immunotherapy methods for patients whose tumors carry a high passenger gene mutation burden
Description
Claims
The ornamental design for a retainer adapter assembly, as shown and described.
Referenced Cited
U.S. Patent Documents
Foreign Patent Documents
Other references
D333184 | February 9, 1993 | Taylor |
D334620 | April 6, 1993 | Taylor |
6610076 | August 26, 2003 | Hellenkamp |
D548833 | August 14, 2007 | Young |
D556904 | December 4, 2007 | Clarke |
D559388 | January 8, 2008 | Melcher |
D613849 | April 13, 2010 | Smutney |
D619705 | July 13, 2010 | Foy |
D664640 | July 31, 2012 | Smutney |
8647299 | February 11, 2014 | Stamp |
D723679 | March 3, 2015 | Neff |
D906516 | December 29, 2020 | Uridil |
D968593 | November 1, 2022 | Tamir |
20150335825 | November 26, 2015 | Soerensen |
20230280148 | September 7, 2023 | Hunter |
20170074969 | June 2017 | KR |
- International Search Report for International Application No. PCT/US2023/063693, dated Jun. 7, 2023 (3 pages).
Patent History
Patent number: D1024321
Type: Grant
Filed: Mar 4, 2022
Date of Patent: Apr 23, 2024
Assignee: Regeneron Pharmaceuticals, Inc. (Tarrytown, NY)
Inventors: Christopher Hunter (Castleton-on-Hudson, NY), Connor Block (Troy, NY)
Primary Examiner: Nathan M Johnston
Application Number: 29/792,127
Type: Grant
Filed: Mar 4, 2022
Date of Patent: Apr 23, 2024
Assignee: Regeneron Pharmaceuticals, Inc. (Tarrytown, NY)
Inventors: Christopher Hunter (Castleton-on-Hudson, NY), Connor Block (Troy, NY)
Primary Examiner: Nathan M Johnston
Application Number: 29/792,127
Classifications
Current U.S. Class:
Support, Holder Or Bracket (20) (D24/128)